ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,791Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 288

$1.56M Total Retail Price of All Prescriptions

Rank: 1 out of 288

953 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 953 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 953 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 27,921 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
OMEPRAZOLE 1,282 1,169 1 3
LEVOTHYROXINE SODIUM 1,219 1,096 2 2
FUROSEMIDE 1,188 1,056 3 5
SIMVASTATIN 1,069 943 4 1
WARFARIN SODIUM 1,048 1,006 5 9
HYDROCODONE-ACETAMINOPHEN 931 812 S3 6 7
AMLODIPINE BESYLATE 882 785 7 6
LISINOPRIL 821 732 8 4
POTASSIUM CHLORIDE 682 588 9 11
METOPROLOL TARTRATE 674 591 10 8
CITALOPRAM HBR 619 526 11 18
DONEPEZIL HCL 506 493 12 29
METFORMIN HCL 471 408 13 12
SERTRALINE HCL 468 423 14 25
TRAMADOL HCL 422 380 15 19
GABAPENTIN 383 286 16 17
MIRTAZAPINE 383 330 16 60
LANTUS 371 287 18 31
QUETIAPINE FUMARATE 367 312 19 92
NAMENDA 316 313 20 39
FENTANYL 307 266 S2 21 57
ALENDRONATE SODIUM 304 252 22 20
ATORVASTATIN CALCIUM 302 261 23 14
PANTOPRAZOLE SODIUM 300 246 24 42
NOVOLOG 297 219 25 91
PREDNISONE 288 270 26 30
ZOLPIDEM TARTRATE 276 219 27 22
METOPROLOL SUCCINATE 272 216 28 15
CLONIDINE HCL 250 181 29 70
TAMSULOSIN HCL 248 237 30 24
CARVEDILOL 242 222 31 27
ATENOLOL 233 229 32 10
CYMBALTA 232 165 33 67
CARBIDOPA-LEVODOPA 217 191 34 72
TRAZODONE HCL 215 152 35 37
IPRATROPIUM-ALBUTEROL 212 203 36 99
HYDROCHLOROTHIAZIDE 203 176 37 13
ISOSORBIDE MONONITRATE ER 200 185 38 35
PAROXETINE HCL 194 183 39 54
FLUTICASONE PROPIONATE 193 158 40 41
LACTULOSE 191 142 41 119
POLYETHYLENE GLYCOL 3350 187 167 42 38
LEVOFLOXACIN 177 150 43 80
OXYBUTYNIN CHLORIDE ER 164 131 44 116
GLYBURIDE 163 157 R 45 59
FAMOTIDINE 156 143 46 68
ROPINIROLE HCL 154 132 47 74
ESCITALOPRAM OXALATE 153 127 48 87
OXYCODONE HCL 151 83 S2 49 127
DIOVAN 150 136 50 53
SPIRONOLACTONE 150 126 50 36
SULFAMETHOXAZOLE-TRIMETHOPRIM 143 118 52 113
BUMETANIDE 141 134 53 105
AMLODIPINE BESYLATE-BENAZEPRIL 140 129 54 89
LOSARTAN POTASSIUM 138 121 55 16
DIGOXIN 137 114 56 51
RANITIDINE HCL 135 94 57 33
LIDODERM 134 110 58 157
SEROQUEL 134 105 58 191
DILTIAZEM 24HR CD 127 113 60 75
CELEBREX 122 121 61 84
HYDRALAZINE HCL 120 104 62 95
NYSTATIN 119 115 63 213
PRAVASTATIN SODIUM 118 109 64 21
NITROFURANTOIN 117 96 65 210
GEMFIBROZIL 117 87 65 77
TRIAMTERENE-HCTZ 116 115 67 28
LYRICA 115 74 68 114
NYSTOP 113 107 69 220
PROPRANOLOL HCL 113 85 69 90
ADVAIR DISKUS 108 106 71 50
AMIODARONE HCL 107 106 72 137
CLOPIDOGREL 105 104 73 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 103 93 74 34
MELOXICAM 101 54 75 44
ALLOPURINOL 98 80 76 23
ONDANSETRON HCL 96 85 77 256
BACLOFEN 96 51 77 121
NITROFURANTOIN MONO-MACRO 93 73 79 293
NABUMETONE 92 74 80 108
TRIAMCINOLONE ACETONIDE 91 82 81 139
BUPROPION XL 90 56 82 179
GLIMEPIRIDE 89 89 83 32
VENLAFAXINE HCL ER 88 36 84 94
OXYBUTYNIN CHLORIDE 86 69 85 69
LEVETIRACETAM 86 66 85 125
LATANOPROST 84 83 87 208
ABILIFY 83 44 88 299
AZITHROMYCIN 82 67 89 49
KLOR-CON M20 81 81 90 110
DILTIAZEM HCL 80 74 91 235
EXELON 79 79 92 185
METOCLOPRAMIDE HCL 79 49 92 128
LIDOCAINE HCL 78 69 94 245
ENALAPRIL MALEATE 78 77 94 40
BENAZEPRIL HCL 78 74 94 52
GLIPIZIDE 76 56 97 56
CYCLOBENZAPRINE HCL 73 42 R 98 73
RISPERIDONE 73 71 98 98
CRESTOR 73 63 98 26
LOPERAMIDE 72 63 101 267
DILTIAZEM ER 72 72 101 102
FINASTERIDE 72 72 101 82
FLUOXETINE HCL 69 55 104 64
METOLAZONE 69 63 104 216
DOXAZOSIN MESYLATE 68 40 106 78
TRAVATAN Z 67 64 107 315
DICYCLOMINE HCL 66 55 108 319
CEPHALEXIN 64 56 109 83
BUSPIRONE HCL 63 42 110 135
PROMETHAZINE HCL 63 35 R 110 198
LEVEMIR 62 49 112 194
IBUPROFEN 60 52 113 111
FLUCONAZOLE 60 30 113 237
PRIMIDONE 60 60 113 280
ZETIA 59 45 116 58
METHADONE HCL 58 20 S2 117 236
AMITRIPTYLINE HCL 57 30 R 118 65
PLAVIX 57 55 118 71
CARBAMAZEPINE 56 38 120 163
SPIRIVA 56 48 120 48
ALBUTEROL SULFATE 56 54 120 133
NEXIUM 54 27 123 43
LEXAPRO 54 44 123 279
HUMALOG 52 52 125 117
KLOR-CON 10 51 40 126 66
OXYCONTIN 51 42 S2 126 182
LANTUS SOLOSTAR 50 31 128 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.